Cutad, Baby Girl .

HRN: 26-76-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2025
AMPICILLIN 250MG (VIAL)
03/02/2025
03/09/2025
IV
75mg
Q12
Psnb
Waiting Final Action 
03/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/02/2025
03/09/2025
IV
15mg
Q36
Psnb
Waiting Final Action 
03/04/2025
CEFOTAXIME 500MG (VIAL)
03/04/2025
03/10/2025
IV
75mg
Q12h
Sepsis
Waiting Final Action 
03/04/2025
CEFOTAXIME 500MG (VIAL)
03/04/2025
03/10/2025
IV
75mg
Q12h
Sepsis
Waiting Final Action 
03/10/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/10/2025
03/17/2025
IV
15mg
Q36
PSNB
Waiting Final Action 
03/11/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/11/2025
03/27/2025
IV
60mg
Q12h
Neonatal Sepsis
Waiting Final Action 
03/11/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
03/11/2025
03/27/2025
IV
5mg
OD
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: